The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Endex 19.5 % w/v Oral Suspension for Cattle

Elanco GmbHVPA22020/035/001

Main Information

Trade NameEndex 19.5 % w/v Oral Suspension for Cattle
Active SubstancesTriclabendazole
Levamisole hydrochloride
Dosage FormOral suspension
Licence HolderElanco GmbH
License Holder AddressHeinz-Lohmann-Strasse 4
27472 Cuxhaven
Licence NumberVPA22020/035/001

Group Information

ATC CodeQP52AC30 combinations of benzimidazoles and related substances
Therapeutic ClassEndoparasiticide


License statusAuthorised
Licence Issued21/10/2016
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back